The trajectory of Viagra, formerly marketed by copyright, presents a intricate case study for stakeholders considering the drug landscape . While its initial success and impact of countless in revenue , the patent end has opened the floodgates for competing medications, greatly eroding earnings prospects . This transition raises doubts about the co